KLF4 and glioblastoma: Our research indicated that either suppressing miR-381 or enhancing NEFL expression sensitizes glioblastoma cells to TMZ by inhibiting stemness factors (ALDH1, CD44, CKIT, KLF4, Nanog, Nestin, and SOX2).